Suresh L. Mehta

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Role of circular RNAs in brain development and CNS diseases”.

Role of circular RNAs in brain development and CNS diseases

Progress in Neurobiology(2020)10.1016/j.pneurobio.2020.101746

N/A

0DataRank · unranked

298 citations

Robert J. Dempsey, Raghu Vemuganti, Suresh L. Mehta

Noncoding RNA crosstalk in brain health and diseases

Neurochemistry International(2021)10.1016/j.neuint.2021.105139

N/A

0DataRank · unranked

52 citations

Anil K. Chokkalla, Raghu Vemuganti, Suresh L. Mehta

CDR1as regulates α-synuclein-mediated ischemic brain damage by controlling miR-7 availability

Molecular Therapy — Nucleic Acids(2022)10.1016/j.omtn.2022.11.022

N/A

0DataRank · unranked

43 citations

Anil K. Chokkalla, Saivenkateshkomal Bathula, Vijay Arruri, Bharath Chelluboina, Raghu Vemuganti +1 more

MicroRNA miR-7 Is Essential for Post-stroke Functional Recovery

Translational Stroke Research(2022)10.1007/s12975-021-00981-7

N/A

0DataRank · unranked

20 citations

Anil K. Chokkalla, Saivenkateshkomal Bathula, Raghu Vemuganti, Suresh L. Mehta

MMP-12 knockdown prevents secondary brain damage after ischemic stroke in mice

Neurochemistry International(2022)10.1016/j.neuint.2022.105432

N/A

0DataRank · unranked

15 citations

Anil K. Chokkalla, Soomin Jeong, Bharath Chelluboina, Suresh L. Mehta, Krishna Kumar Veeravalli +2 more

Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage

NeuroMolecular Medicine(2022)10.1007/s12017-022-08731-0

N/A

0DataRank · unranked

15 citations

TaeHee Kim, Bharath Chelluboina, Raghu Vemuganti, Suresh L. Mehta

Tau and GSK-3β are critical contributors to α-synuclein-mediated post-stroke brain damage

Research Square(2022)10.21203/rs.3.rs-2106108/v1

N/A

0DataRank · unranked

1 citations

TaeHee Kim, Bharath Chelluboina, Raghu Vemuganti, Suresh L. Mehta

Post-stroke brain can be protected by modulating the lncRNA FosDT

Journal of Cerebral Blood Flow & Metabolism(2023)10.1177/0271678x231212378

N/A

0DataRank · unranked

20 citations

Bharath Chelluboina, Kahlilia C. Morris-Blanco, Saivenkateshkomal Bathula, Soomin Jeong, Vijay Arruri +3 more

Therapeutic Potential of Intravenous miR-21 Mimic after Stroke Following STAIR Criteria

Translational Stroke Research(2023)10.1007/s12975-023-01223-8

N/A

0DataRank · unranked

5 citations

Soomin Jeong, Charles K. Davis, Suresh L. Mehta, Raghu Vemuganti, Bharath Chelluboina

Intermittent fasting induced cerebral ischemic tolerance altered gut microbiome and increased levels of short-chain fatty acids to a beneficial phenotype

Neurochemistry International(2024)10.1016/j.neuint.2024.105795

N/A

0DataRank · unranked

8 citations

Tony Cho, Jin-Soo Park, Suresh L. Mehta, Saivenkateshkomal Bathula, Soomin Jeong +2 more

Role of transcription factors, noncoding RNAs, epitranscriptomics, and epigenetics in post‐ischemic neuroinflammation

Journal of Neurochemistry(2024)10.1111/jnc.16055

N/A

0DataRank · unranked

7 citations

Vijay Arruri, Raghu Vemuganti, Suresh L. Mehta

Stroke triggers dynamic m6A reprogramming of cerebral circular RNAs

Neurochemistry International(2024)10.1016/j.neuint.2024.105802

N/A

0DataRank · unranked

2 citations

Hadjer Namous, Raghu Vemuganti, Suresh L. Mehta

Loss of Epitranscriptomic Modification N6-Methyladenosine (m6A) Reader YTHDF1 Exacerbates Ischemic Brain Injury in a Sexually Dimorphic Manner

Translational Stroke Research(2024)10.1007/s12975-024-01267-4

N/A

0DataRank · unranked

3 citations

Vijay Arruri, Suresh L. Mehta, Raghu Vemuganti, Anil K. Chokkalla